A section of Journal of Clinical Medicine (ISSN 2077-0383).
The recent progress in the field of infectious diseases has been remarkable. Many diseases and conditions, including autoimmune diseases, allergy-related diseases, and malignant diseases have been associated with infectious diseases. Bacteria, parasites, and especially viruses can interfere with the host immune system and induce chronic self-perpetuating conditions. Therefore, the study of the pathogenesis of chronic diseases triggered by infectious agents is playing an increasingly important role as the bridge between basic research and clinical practice, and the significance of translational research has been rapidly increasing in recent years.
In clinical practice, the prevention and treatment of viral infections can contribute to reducing and preventing inflammatory chronic disorders, neoplasms, and various other pathologies.
Finally, chronic infections can represent a relevant factor that influences the treatment and management of metabolic, inflammatory, and neoplastic conditions. Guidelines and recommendations from scientific societies are needed to apply the correct approach for handling these patients.
The section “Infectious Diseases” of the Journal of Clinical Medicine aims to publish articles describing research results on microbiology, immunology, epidemiology, and related disciplines on the pathogenesis, diagnosis, and treatment of infectious diseases, with a particular focus on the role of infections in the pathogenesis of chronic non-infectious conditions as well as on the treatment of infections as comorbidities of chronic conditions.
Hot research topics include, but are not limited to:
- Infectious diseases epidemiology
- Anti-infective therapy and vaccines
- Emerging infectious diseases
- Role of infections in pathogenesis of chronic non-infectious conditions
- Chronic infections as comorbidities of neoplasms or metabolic and inflammatory disorders
- Infectious adverse events of immunosuppressive or anti-neoplastic drugs
Following special issues within this section are currently open for submissions:
- Clinical Health Care during the COVID-19 Pandemic: Therapeutic and Management Strategies (Deadline: 30 June 2021)
- Coronavirus Disease 2019: Clinical Presentation, Pathogenesis and Treatment (Deadline: 31 July 2021)
- Clinical Management and Epidemiology of HIV and Hepatitis Virus Co-infected Patients (Deadline: 5 August 2021)
- Virus Infection and Antiviral Drugs (Deadline: 31 August 2021)
- Nutrition–Microbiota–Cancer Triad: Pros and Cons (Deadline: 30 September 2021)
- Chronic HCV Infection: Clinical Advances and Eradication Perspectives (Deadline: 30 September 2021)
- Exosomes Biogenesis, Regulation, and Function in Viral Infections (Deadline: 30 September 2021)
- Natural History and Clinical Consequences of Hepatitis B Virus (HBV) Infection (Deadline: 30 September 2021)
- Current Trends and Outcomes of Infective Endocarditis (Deadline: 30 September 2021)
- Oncogenic Human Papillomaviruses (Deadline: 15 October 2021)
- Issues and Challenges of Ventilator Associated Pneumonia in COVID-19 (Deadline: 31 October 2021)
- Updates in Management of SARS-CoV-2 Infection (Deadline: 1 November 2021)
- Current Advances in Lung Ultrasound for COVID-19 (Deadline: 15 December 2021)
- Current Scientific Advances in the Prevention, Diagnosis and Treatment of Parasitic Diseases (Deadline: 15 December 2021)
- COVID-19: Therapeutics (Deadline: 20 December 2021)
- Biomaterials and Advanced Therapies against Virus: How Could They Help Us for Corona Virus Infection? (Deadline: 31 December 2021)
- Human Papillomavirus: Experiences about Molecular Biology, Clinical Research, and Real Clinical Practice (Deadline: 31 December 2021)
- Advances in Mycoplasma pneumoniae Infections (Deadline: 31 January 2022)
- Helicobacter Pylori Infection and Related Diseases: Advances in Diagnosis and Therapeutic Management (Deadline: 1 February 2022)
- Acute and Early HIV Infection (Deadline: 31 March 2022)